Helen Collette
Nurse Practitioner · Auburn, MANPI 1376731679
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $703 and has fallen 97.4% since, to $19 in 2025. Among nurse practitioner clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 88 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$399
- Lilly USA, LLC$395
- Novo Nordisk$255
- AstraZeneca$186
- Abbott$76
- Astellas Pharma US Inc$74
- plus $444 from 14 others
What the payments were for
- Food & beverage$1,828100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 18 | $399 |
| Lilly USA, LLC | 18 | $395 |
| Novo Nordisk | 13 | $255 |
| AstraZeneca | 10 | $186 |
| Abbott | 4 | $76 |
| Astellas Pharma US Inc | 3 | $74 |
| E.r. Squibb & Sons, L.L.C. | 3 | $70 |
| Exact Sciences | 2 | $61 |
| Phathom Pharmaceuticals, Inc. | 2 | $44 |
| Idorsia Pharmaceuticals US Inc | 2 | $42 |
| Boehringer Ingelheim | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $33 |
| Ardelyx, Inc. | 1 | $30 |
| Bayer | 2 | $25 |
| Pfizer | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Novartis | 1 | $16 |
| Amgen | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
How this compares
$1,828 in reported general payments places this provider in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 30 | $295 |
| Gabapentin | 32 | $290 |
| Levothyroxine Sodium | 18 | $112 |
| Tamsulosin Hcl | 11 | $91 |
| Lisinopril | 11 | $40 |
| Simvastatin | 11 | $39 |
| Hydrochlorothiazide | 14 | $34 |
| Prednisone | 15 | $30 |
| Lorazepam | 13 | $10 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Auburn
- Lauri WelchNorth Chelmsford$110K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Deborah GearySalem$80K
- Amberly ChaplinWorcester$56K
- Darlene MadoreBrockton$42K
- Nancy SydowN Chelmsford$35K
- Miu Lai NgBoston$33K
- Victoria Garcia AlbeaStoneham$31K
- Lauren BurkeBoston$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.